Quality of Life With TESTIM in Testosterone Replacement Therapy for Male Patients With Hypogonadism.

Trial Profile

Quality of Life With TESTIM in Testosterone Replacement Therapy for Male Patients With Hypogonadism.

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Dec 2011

At a glance

  • Drugs Testosterone (Primary)
  • Indications Hypogonadism
  • Focus Therapeutic Use
  • Sponsors Ferring Pharmaceuticals
  • Most Recent Events

    • 21 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 21 Dec 2011 Actual end date (Jul 2011) added as reported by ClinicalTrials.gov.
    • 13 Apr 2011 Planned end date changed from 1 Jun 2011 to 1 Oct 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top